[go: up one dir, main page]

NO20025765D0 - Kombinasjonssett for behandling av malaria - Google Patents

Kombinasjonssett for behandling av malaria

Info

Publication number
NO20025765D0
NO20025765D0 NO20025765A NO20025765A NO20025765D0 NO 20025765 D0 NO20025765 D0 NO 20025765D0 NO 20025765 A NO20025765 A NO 20025765A NO 20025765 A NO20025765 A NO 20025765A NO 20025765 D0 NO20025765 D0 NO 20025765D0
Authority
NO
Norway
Prior art keywords
malaria
treatment
combination kit
kit
combination
Prior art date
Application number
NO20025765A
Other languages
English (en)
Other versions
NO20025765L (no
NO324774B1 (no
Inventor
Francis Joseph Pinto
Swati Ajay Piramal
Ram Pratap
Amiya Prasad Bhaduri
Harsh Pati Thapliyal
Sunil Kumar Puri
Guru Prasad Dutta
Anil Kumar Dwivedi
Satyawan Singh
Pratima Srivastava
Vikash Chandra Pandey
Sudhir Srivastava
Shio Kumar Singh
Ram Chandra Gupta
Jagdishwar Sahai Srivastava
Omkar Prasad Asthana
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of NO20025765D0 publication Critical patent/NO20025765D0/no
Publication of NO20025765L publication Critical patent/NO20025765L/no
Publication of NO324774B1 publication Critical patent/NO324774B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47064-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20025765A 2000-05-31 2002-11-29 Kombinasjonssett for behandling av malaria NO324774B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31
PCT/IN2000/000081 WO2001091535A2 (en) 2000-05-31 2000-08-30 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält

Publications (3)

Publication Number Publication Date
NO20025765D0 true NO20025765D0 (no) 2002-11-29
NO20025765L NO20025765L (no) 2003-01-08
NO324774B1 NO324774B1 (no) 2007-12-10

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025765A NO324774B1 (no) 2000-05-31 2002-11-29 Kombinasjonssett for behandling av malaria

Country Status (28)

Country Link
US (1) US7404962B1 (no)
EP (1) EP1292306B1 (no)
JP (1) JP2004505017A (no)
KR (1) KR20030025926A (no)
AP (1) AP1435A (no)
AR (1) AR028458A1 (no)
AT (1) ATE314848T1 (no)
AU (2) AU2879001A (no)
BR (1) BR0005247A (no)
CA (1) CA2413775C (no)
CR (1) CR6835A (no)
CZ (1) CZ296875B6 (no)
DE (2) DE00993875T1 (no)
DK (1) DK1292306T3 (no)
EC (1) ECSP003694A (no)
ES (1) ES2200729T3 (no)
GT (1) GT200000187A (no)
HK (1) HK1052467B (no)
HN (1) HN2001000118A (no)
HU (1) HUP0301925A3 (no)
MX (1) MXPA02011883A (no)
NO (1) NO324774B1 (no)
OA (1) OA12276A (no)
PE (1) PE20011319A1 (no)
PL (1) PL200748B1 (no)
SV (1) SV2002000201A (no)
WO (1) WO2001091535A2 (no)
ZA (1) ZA200209726B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2642672A1 (en) * 2006-02-16 2007-08-30 The Mclean Hospital Corporation Methods and compositions for the treatment of parkinson's disease
US8658648B2 (en) 2008-12-05 2014-02-25 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
FI934360A0 (fi) * 1992-02-07 1993-10-04 Ciba Geigy Ag Synergistiska antimalariakompositioner innehaollande benflumetol

Also Published As

Publication number Publication date
PL372718A1 (en) 2005-07-25
WO2001091535B1 (en) 2002-10-31
CR6835A (es) 2007-04-26
CA2413775C (en) 2009-08-25
AR028458A1 (es) 2003-05-07
DK1292306T3 (da) 2006-05-22
DE60025403T2 (de) 2006-08-24
AU2001228790B2 (en) 2007-02-01
DE60025403D1 (de) 2006-03-30
DE00993875T1 (de) 2004-04-15
OA12276A (en) 2006-05-10
ES2200729T1 (es) 2004-03-16
HUP0301925A2 (hu) 2003-09-29
WO2001091535A3 (en) 2002-07-04
HN2001000118A (es) 2001-10-29
EP1292306A2 (en) 2003-03-19
KR20030025926A (ko) 2003-03-29
CA2413775A1 (en) 2001-12-06
AP2002002672A0 (en) 2002-12-31
NO20025765L (no) 2003-01-08
AP1435A (en) 2005-06-21
EP1292306B1 (en) 2006-01-04
ATE314848T1 (de) 2006-02-15
BR0005247A (pt) 2002-02-13
HUP0301925A3 (en) 2009-03-30
JP2004505017A (ja) 2004-02-19
GT200000187A (es) 2002-04-18
SV2002000201A (es) 2002-10-24
NO324774B1 (no) 2007-12-10
MXPA02011883A (es) 2004-05-17
HK1052467B (en) 2006-03-10
CZ20024071A3 (cs) 2003-04-16
ECSP003694A (es) 2002-01-25
WO2001091535A2 (en) 2001-12-06
PL200748B1 (pl) 2009-02-27
CZ296875B6 (cs) 2006-07-12
ZA200209726B (en) 2004-03-10
PE20011319A1 (es) 2002-03-02
AU2879001A (en) 2001-12-11
ES2200729T3 (es) 2006-07-16
US7404962B1 (en) 2008-07-29
HK1052467A1 (en) 2003-09-19

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
ID30590A (id) Celana sekali pakai jenis-celana pendek
FI20010694A0 (fi) Implantti
ID30187A (id) Dongkrak jenis pantagraf
DE60214255D1 (de) Schlussstück
EE05020B1 (et) Glburiidi ravimkoostis
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
NO20032122D0 (no) Forbedret behandling
NO20041968L (no) Anvendelse av cystationin
IS2523B (is) Turn vindorkuvers
DE60216563D1 (de) Führungsdraht
DE60203208D1 (de) Führungsdraht
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
ES1045691Y (es) Ducha
NO20025765L (no) Kombinasjonssett for behandling av malaria
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
ITMI20011820A0 (it) Trattamento di ustioni
DE50209548D1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen
NO20041687L (no) Sluttstykke
FIU20000034U0 (fi) Kanteleen sävelvaihtomekanismi
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
NO20015559D0 (no) Kreklinggel±

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees